Institut Català de la Salut
[Esmel-Vilomara R] Faculty of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Pediatric Cardiology, Hospital de la Santa Creu i Sant Pau, Institut de Recerca Sant Pau (IR Sant Pau), Barcelona, Spain. [Figueras-Coll M] Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Pediatric Cardiology, Hospital Universitari Doctor Josep Trueta, Girona, Spain. [Rosés-Noguer F, Gran F] Faculty of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Cardiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. [Balcells J] Faculty of Medicine, Universitat Autònoma de Barcelona, Bellaterra, Spain. Unitat de Cures Intensives Pediàtriques, Vall d’Hebron Hospital Universitari, Barcelona, Spain
Vall d'Hebron Barcelona Hospital Campus
2025-04-22T10:49:21Z
2025-04-22T10:49:21Z
2025-03-19
Diphtheria; Diphtheria antitoxin; Vaccination
Diftèria; Antitoxina diftèrica; Vacunació
Difteria; Antitoxina diftérica; Vacunación
Background Diphtheria, a preventable yet potentially fatal childhood disease, remains a significant threat to unimmunized children, despite its decreased prevalence due to widespread vaccination. Case Summary A 6-year-old unvaccinated Spanish boy presented with diphtheritic myocarditis. His condition rapidly deteriorated, leading to cardiogenic shock and ventricular tachycardia, necessitating the use of venoarterial extracorporeal membrane oxygenation and the international procurement of diphtheritic antitoxin (DAT). Discussion Myocarditis stands as the primary cause of mortality in diphtheria. Early DAT administration is crucial, but its effectiveness diminishes once the diphtheria toxin binds to tissues, and global accessibility may be challenging due to limited production. In scenarios of refractory cardiogenic shock, the employment of mechanical circulatory support, specifically with left cavity drainage systems, can be vital. Take Home Messages Timely vaccination is crucial in preventing diphtheria-related fatalities. Global access to essential treatments like DAT remains a significant challenge.
Article
Published version
English
Diftèria - Vacunació; Miocarditis - Tractament; Teràpia respiratòria; Xoc cardiogènic; Taquicàrdia; Antitoxines; Infants; DISEASES::Bacterial Infections and Mycoses::Bacterial Infections::Gram-Positive Bacterial Infections::Actinomycetales Infections::Corynebacterium Infections::Diphtheria; DISEASES::Cardiovascular Diseases::Heart Diseases::Cardiomyopathies::Myocarditis; Other subheadings::Other subheadings::/therapy; DISEASES::Cardiovascular Diseases::Heart Diseases::Myocardial Ischemia::Myocardial Infarction::Shock, Cardiogenic; DISEASES::Cardiovascular Diseases::Heart Diseases::Arrhythmias, Cardiac::Tachycardia::Tachycardia, Ventricular; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Respiratory Therapy::Extracorporeal Membrane Oxygenation; CHEMICALS AND DRUGS::Amino Acids, Peptides, and Proteins::Proteins::Blood Proteins::Immunoproteins::Immunoglobulins::Antibodies::Immune Sera::Antitoxins::Diphtheria Antitoxin; ANALYTICAL, DIAGNOSTIC AND THERAPEUTIC TECHNIQUES, AND EQUIPMENT::Therapeutics::Biological Therapy::Immunomodulation::Immunotherapy::Immunization::Immunotherapy, Active::Vaccination; NAMED GROUPS::Persons::Age Groups::Child; ENFERMEDADES::infecciones bacterianas y micosis::infecciones bacterianas::infecciones por bacterias grampositivas::infecciones por Actinomycetales::infecciones por Corynebacterium::difteria; ENFERMEDADES::enfermedades cardiovasculares::enfermedades cardíacas::miocardiopatías::miocarditis; Otros calificadores::Otros calificadores::/terapia; ENFERMEDADES::enfermedades cardiovasculares::enfermedades cardíacas::isquemia miocárdica::infarto de miocardio::choque cardiogénico; ENFERMEDADES::enfermedades cardiovasculares::enfermedades cardíacas::arritmias cardíacas::taquicardia::taquicardia ventricular; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia respiratoria::oxigenación por membrana extracorpórea; COMPUESTOS QUÍMICOS Y DROGAS::aminoácidos, péptidos y proteínas::proteínas::proteínas sanguíneas::inmunoproteínas::inmunoglobulinas::anticuerpos::sueros inmunes::antitoxinas::antitoxina diftérica; TÉCNICAS Y EQUIPOS ANALÍTICOS, DIAGNÓSTICOS Y TERAPÉUTICOS::terapéutica::terapia biológica::inmunomodulación::inmunoterapia::inmunización::inmunoterapia activa::vacunación; DENOMINACIONES DE GRUPOS::personas::Grupos de Edad::niño
Elsevier
JACC: Case Reports;30(6,1)
https://doi.org/10.1016/j.jaccas.2024.102972
Attribution-NonCommercial-NoDerivatives 4.0 International
http://creativecommons.org/licenses/by-nc-nd/4.0/
Articles científics - HVH [3439]